Senior Leadership

Diarmuid comes to Cambridge Enterprise from his role as Chief Innovation & Enterprise Officer at Trinity College Dublin, where he had overall responsibility for the development and enhancement of the college’s innovation and enterprise strategy. 

Prior to this, Diarmuid was Director of Trinity Research and Innovation with responsibility for both the Research Development Office and the Office of Corporate Partnership and Knowledge Exchange. In that role he led the establishment of the University Bridge venture fund, which is ranked in the world’s top five collaborative university funds, according to Global University Venturing.

While at Trinity, Diarmuid was also the Executive Director of CRANN, an internationally recognised centre of excellence for nanotechnology and materials science research.

He has held senior management roles in several university-founded start-up companies, including NTera, Xoliox, and Deerac Fluidics.

Diarmuid was a Research Fellow at Princeton University. He has a PhD in Physics from the University of Sheffield and a degree in Materials Science from Trinity College Dublin. He joined Cambridge Enterprise in August 2021.

Paul is Deputy Director of Cambridge Enterprise. He is responsible for implementing a five year strategy that aims to enhance our customer service so that we can help more academics, researchers, companies and investors to create a positive impact on society. A cornerstone of the strategy is the introduction of a new IT system that will enable customers to access data as well as driving greater efficiency within the business.

Paul was previously Head of Consultancy Services for six years, during which period he doubled the team’s turnover. He is a Board member and Director of three University of Cambridge subsidiary companies: Cambridge Enterprise Limited, Cambridge University Technical Services (CUTS) Limited and Institute for Manufacturing Education and Consultancy Services Limited.

Paul has considerable experience of technology transfer in both the biotech and medtech sectors. He was previously Head of Business Development at Health Enterprise East, where he was instrumental in building a successful technology transfer and consultancy organisation for the NHS. Before that, he was a Technology Manager at Cambridge Enterprise for more than three years and led its Life Sciences team. Paul also spent five years as a Senior Scientist with a Cambridge biotech company that had spun out of the University, helping it to develop its medtech business.

Paul has a degree in Biochemistry and a PhD in Chemistry from Manchester. After his PhD, he became a post-doctoral researcher for the Medical Research Council and then later for the University of Cambridge.

Paul first joined Cambridge Enterprise in 2001 and returned after he completed his time with Health Enterprise East in 2009.

Boris is responsible for the Business Support team and for information analysis and reporting.

He oversees project developments and the IP portfolio management system, as well as related processes and management information reporting.

Prior to his current post, Boris held several roles at Cambridge Enterprise including Business Support Manager and Senior Technology Associate in the Life Sciences team.

Before joining Cambridge Enterprise, Boris worked as a research associate for an international executive search consultancy providing senior manager and executive recruitment services to the life science and healthcare industries.

Boris has an MSc in Biology from the University of Montpellier (France) and Level 5 Award in Management from the Institute of Leadership and Management.

Boris joined the Technology Transfer Office of the University (which became Cambridge Enterprise in 2006) in September 2003.

Formerly leading our Seed Funds team, and now working with the Senior Leadership Team on future projects and planning, Anne has previously overseen strong growth in our investment activities.

Recent highlights include the purchase of Cambridge CMOS Sensors by ams, and the sale of Quethera to Astellas Pharma. Anne has also served on many boards including those of Cambridge CMOS Sensors, Aqdot, Cambridge Touch Technologies, Psyomics, MorphoenIX and Quethera. She was a founding member of Praxis Auril, which supports Knowledge Exchange Commercialisation in the UK.

Anne’s early career includes experience in technology transfer at Imperial College Innovations Limited, in pharmaceutical development at Evans Medical, and in pharmaceutical product training at Information Transfer.

Anne holds a BSc in Medical Microbiology and a PhD in Immunology.

Anne joined the technology transfer team at the University of Cambridge in 2001, and has been involved with Cambridge Enterprise since its foundation in 2006, including as Interim Director just prior to this. She joined the Seed Funds team in 2008 and was appointed Head of Seed Funds in 2011.

As Head of Ecosystem Initiatives and Partnerships, Caroline leads on a number of strategic activities designed to support entrepreneurship and innovation.

Delivering the company’s convening agenda, the activity is about connecting two pivotal ecosystems – the University and the wider Cambridge ecosystem – in a proactive and strategic way that drives entrepreneurship and innovation. Cambridge Enterprise sits as a bridge between these ecosystems – intrinsically linked to both – and this activity helps to shape and support emerging entrepreneurs, spin-outs and start-ups and the companies who are forging the innovation landscape of Cambridge for the future.

Caroline works closely with the Innovate Cambridge initiative helping to create an inclusive, ambitious and broad-ranging innovation vision for the Greater Cambridge area; the University Enterprise Network which helps convene all of the University’s activities for entrepreneurship and innovation; the ideaSpace community and network bringing together Cambridge founders; and International Outreach which enables us to share our experience and expertise around the globe.

Caroline joins from her previous role as CEO for Allia Future Business Centres Ltd where she established an initial innovation and incubation centre for social ventures and ‘tech for good’ companies and built out a network of four centres operating across Cambridge, London and Peterborough. Caroline has spent over 20 years working with entrepreneurship and innovation in and around Cambridge and is well networked in the Cambridge ecosystem. She brings this, as well as previous experience working in a research, development and commercialisation department of a UK University, to ensure that international partners benefit from the richest experience of engagement.

Caroline is a Fellow of the RSA.

Caroline joined Cambridge Enterprise in March 2020.

As Head of Seed Funds, Christine oversees our investment activities, with the team investing over £5 million each year in young companies.

With expertise in Life Science investment, Christine has a focus on drug discovery with a broad portfolio of technologies, including University of Cambridge spin-outs Carrick, STORM, Z-factor, PhoreMost, Qkine, and PolyProX. Christine was featured in BioBeat’s 50 Movers and Shakers in BioBusiness 2018.

Previously, Christine worked for six years in the Life Sciences Tech Transfer team managing licensing of University IP. Christine also managed the University of Cambridge-GSK open innovation drug discovery initiative based at the SBC, working closely with academics to gain funding to develop translational projects.

Prior to that, she enjoyed 11 years working for Biotica, a biotechnology spin-out from the University of Cambridge as Department Director and Project Leader.

Christine has an MA and DPhil from the University of Oxford. She is the author of over 20 peer reviewed journal articles and over 20 patents. She was also the recipient of the Arthur E. Schwarting award for the best article published in the Journal of Natural Products in 2006.

Christine joined Cambridge Enterprise in September 2011.

Marcio leads the Physical Sciences team at Cambridge Enterprise, working to help researchers commercialise technologies from across the whole range of the Schools of Physical Sciences and Technology.

Prior to joining Cambridge Enterprise, Marcio was with Imperial College London in a similar role for close to two years. Before that, Marcio enjoyed working in his own company in the field of scientific instrumentation for high pressure research, from where he exited in 2018, after 16 years.  At the time of his exit the company had offices in the UK, US, Belgium and China.  Previous to this, he worked for a medical devices company with full new product development and introduction responsibilities.

His scientific background is in physics, with a PhD from Royal Holloway, University of London.  He also has an MBA from the University of Surrey and is a Certified Licensing Professional.

Marcio joined Cambridge Enterprise in March 2021.

Iain is Head of Life Sciences at Cambridge Enterprise, responsible for a team that is working across the life sciences sector from human health therapeutics to agritech and research tools. Iain has a PhD in Organic Chemistry (Sydney) and MBA (Cambridge).

The team has spun-out companies including X01 Therapeutics, Apcintex (now a Centessa company), DIOSynVax, NoBACZ Healthcare, Predictimmune Limited, PhoreMost, Z-factor and Cambridge Epigenetix. Iain, with colleagues from partner universities founded Apollo Therapeutics, a £40 million fund in early stage drug development and launched the Ceres Agritech Knowledge Exchange Partnership. Iain also led discussions with GSK in respect of the University of Cambridge-GSK open innovation drug discovery initiative based at the Stevenage Bioscience Catalyst.

Iain joined Cambridge Enterprise in November 2003.

Leading the marketing and communications team, Joanna is responsible for the strategic marketing, communications and promotion of Cambridge Enterprise and its services to all audiences. She also leads on the marketing operations elements of the team, including technical functionality and processes.

Joanna manages a variety of projects and programmes focused on commercialisation of University innovations, knowledge and expertise for societal impact, raising awareness of our services and driving engagement with the University and the wider external community.

Prior to joining Cambridge Enterprise in 2004, Joanna worked in the financial services sector.

Joanna is a Chartered Marketer, a Member of the Chartered Institute of Marketing and a Member of the Chartered Institute of Public Relations.

As CTO, Matt’s role involves leading the IT team, working with Cambridge Enterprise strategic project groups to provide expertise, support and advice on their IT requirements, developing the IT strategy, and researching, recommending and project managing new IT technology solutions, thus helping Cambridge Enterprise engage with its customers, streamline business processes, and allow staff to be more effective.

Graduating from Cambridge in Engineering, Matt followed a career in web design and development, then enterprise applications and finally the full IT portfolio, working for many years in the media sector (Emap plc and The Guardian), but more recently a Tennessee software company and Cambridgeshire County Council.

Matt is a Fellow of the Chartered Management Institute, having completed a Masters in Business Administration (MBA) at Anglia Ruskin University, and also attained Chartered IT Professional (CITP) status whilst studying IT Leadership at Cranfield University.

Matt joined Cambridge Enterprise in January 2019.

Amanda is Head of Consultancy Services and Research Tools, a fast-growing service dedicated to generating both societal and economic impact from academic research by facilitating consultancy between University academics from across all disciplines within the University and external organisations.

The Consultancy Services team has supported almost 400 consultancy projects this past year of which many arose from Arts, Humanities or Social Science disciplines. In 2017-18, Amanda’s team saw a 63% increase in the number of new consultants with deals signed for 165 academics and 234 clients in that period.

Amanda periodically delivers training to technology transfer professionals for PraxisAuril, the Association of University Technology Managers (AUTM) and the European Association for Technology Transfer Professionals (ASTP), and is on the Board of Directors for ASTP as VP for Professional Development.

Amanda previously worked for the University of Nottingham’s School of Pharmacy, where she ran a newly created interdisciplinary Doctoral Training Centre. As Project Manager, she co-ordinated the PhD programme and brought together academics and industry to generate collaborative research projects in targeted therapeutics as well as running a government-funded project to develop researchers’ transferable skills. She has also worked for the Food Standards Agency in scientific policy and for Isis Research (now known as Synovate Healthcare) where she was responsible for planning, implementing and analysing large international studies on HIV therapy for the pharmaceutical industry.

Amanda has a PhD in HIV research from the MRC-Laboratory of Molecular Biology at the University of Cambridge.

Amanda joined Cambridge Enterprise as Consultancy Associate in January 2008 and became Head of Consultancy in February 2015.